|By PR Newswire||
|January 10, 2014 08:00 AM EST||
-- Leadership Appointment Bolsters API Business and Sales Strategies
ALBANY, New York, Jan. 10, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of George Svokos, to the newly created position of Senior Vice President Sales and General Manager API, effective January 6, 2014. Mr. Svokos will report to William S. Marth, President and Chief Executive Officer.
"Mr. Svokos is a strategic thinker who comes to AMRI with years of experience in pharmaceutical manufacturing, business development, R&D, and sales and marketing," said Mr. Marth. "With his experience handling a large sales force in a multibillion dollar business, Mr. Svokos' main focus is to develop a commercial strategy around active pharmaceutical ingredients (APIs), as well as to assist on the sales side of the business."
Before coming to AMRI, Mr. Svokos had been with Teva Pharmaceuticals Industries Ltd. since 1979. Most recently, he was Senior Vice President of Product and Portfolio Selection, and Business Development, responsible for strategic planning, portfolio selection, new product introductions and business development. From 2011 to 2012, Mr. Svokos was Senior Vice President, US Technical Operations, responsible for strategic planning, manufacturing, supply chain, regulatory and legal compliance, and safety, for eleven U.S. dosage form manufacturing facilities, as well as supply of branded and generic products to the U.S. market from overseas plants in Europe, the Middle East, China and India. Before this role, he served as Executive Vice President of Commercial Operations, Teva API, leading the global sales and marketing of Teva's API division, including a global sales force, with multibillion-dollar sales. Mr. Svokos is the Senior Vice President of the Drug, Chemical & Associated Technologies Association (DCAT) and will become President next year.
Mr. Svokos earned a Master's degree in Business Administration from the University of Missouri and a Bachelor's of Science degree in Chemical Engineering from Columbia University.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 22 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers with informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).
May. 29, 2016 10:30 AM EDT Reads: 1,286
May. 29, 2016 10:30 AM EDT Reads: 1,255
May. 29, 2016 10:00 AM EDT Reads: 2,489
May. 29, 2016 09:45 AM EDT Reads: 2,018
May. 29, 2016 09:30 AM EDT Reads: 2,297
May. 29, 2016 08:15 AM EDT Reads: 2,733
May. 29, 2016 07:00 AM EDT Reads: 2,292
May. 29, 2016 06:45 AM EDT Reads: 2,943
May. 29, 2016 06:00 AM EDT Reads: 2,163
May. 29, 2016 06:00 AM EDT Reads: 1,340
May. 29, 2016 05:15 AM EDT Reads: 3,272
May. 29, 2016 05:00 AM EDT Reads: 1,969
May. 29, 2016 04:30 AM EDT Reads: 3,250
May. 29, 2016 03:30 AM EDT Reads: 986
May. 29, 2016 02:45 AM EDT Reads: 1,495
May. 29, 2016 02:00 AM EDT Reads: 1,340
May. 29, 2016 01:30 AM EDT Reads: 2,483
May. 29, 2016 01:00 AM EDT Reads: 1,426
May. 29, 2016 12:45 AM EDT Reads: 2,058
May. 28, 2016 11:00 PM EDT Reads: 2,384